IBD
Myths and Misconceptions in the Management of Elderly Patients With Inflammatory Bowel Disease
Feature
Is It Time for Noncontinuous Therapy for Gastroesophageal Reflux Disease?
Abstract: Gastroesophageal reflux disease (GERD) is a chronic disorder characterized by the reflux of gastric contents into the esophagus, leading to symptoms and potential long-term complications […]
In This Issue
From Recent Issues
Feature
Family Planning for Patients With Inflammatory Bowel Disease in the Post-Dobbs Era
Abstract: Federal protections for abortion care in the United States ended in June 2022. For people with inflammatory bowel disease (IBD) who are capable of pregnancy, […]
Feature
A Clinical Review of Noninvasive Tests for Hepatic Fibrosis
Abstract: Identifying hepatic fibrosis is paramount in managing patients with chronic liver disease. The etiology of liver disease can be owing to many factors, including chronic […]
Feature
Is It Time for Noncontinuous Therapy for Gastroesophageal Reflux Disease?
Abstract: Gastroesophageal reflux disease (GERD) is a chronic disorder characterized by the reflux of gastric contents into the esophagus, leading to symptoms and potential long-term complications […]
Supplements
Highlights in Ulcerative Colitis From Digestive Disease Week 2023
A Review of Selected Presentations From DDW 2023 • May 6-9, 2023 • Chicago, Illinois Long-Term Safety of 3 Years of Ozanimod in Moderately to Severely […]
Ulcerative Colitis
Highlights in Ulcerative Colitis From the American College of Gastroenterology Annual Scientific Meeting
A Review of Selected Presentations From ACG 2022 October 21-26, 2022 • Charlotte, North Carolina Duration of Response to Ozanimod After Treatment Withdrawal: Results From the […]
Ulcerative Colitis
Highlights in Ulcerative Colitis From the 17th Congress of the European Crohn’s and Colitis Organisation
Rapidity of Ozanimod-Induced Symptomatic Response and Remission in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Induction Period of True North Ozanimod is […]
Liver Disease
Nonalcoholic Fatty Liver Disease in Children
Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. It represents a spectrum of disease from simple hepatic steatosis to steatohepatitis […]
A Systematic Approach to Pregnancy-Specific Liver Disorders
Abstract: Consultation for liver disease during pregnancy is challenging for both the hepatologist and gynecologist, as normal physiologic changes during pregnancy can mimic chronic liver disease. […]
Advances in the Management of Renal Dysfunction in Patients With Cirrhosis
Abstract: Renal dysfunction frequently develops in patients with advanced liver disease. Renal dysfunction in this setting is associated with adverse outcomes and an unfavorable prognosis. Hepatorenal […]